share_log
Benzinga ·  Jan 13 13:30
EXCLUSIVE: Artelo Biosciences Tells Benzinga Co. Announces Successful Completion Of The Safety Review Of The First Cohort Of Eight Healthy Volunteers In A Phase I Study Of ART26.12
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 266

Recommended

Write a comment